What is Afatinib?

Category: Prescription Drugs

Most popular types: Gilotrif

false

Afatinib is an orally administered kinase inhibitor that may be used for the first-line treatment of non-small cell lung cancer (NSCLC) in patients whose tumor are positive for certain mutations of the epidermal growth factor receptor (EGFR).

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 1
Moderate 6
Mild 4
None 1

Commonly reported side effects and conditions associated with Afatinib

Side effect Patients
Diarrhea 5
Dry skin 3
Dry mouth 2
Paronychia 2
Rash or skin problems 2
Acne 1

Show all 35 reported side effects

Dosages

Based on patients currently taking Afatinib

Dosage Patients
30 mg daily 4
40 mg daily 4
20 mg daily 3

Why patients stopped taking Afatinib

Multiple reasons could be selected

Reason Patients
Did not seem to work 1
Doctor's advice 1
See all 2 patients who've stopped taking Afatinib

Duration

Currently taking Afatinib

Duration Patients
1 - 6 months 1
6 months - 1 year 2
1 - 2 years 6
2 - 5 years 2

Stopped taking Afatinib

Duration Patients
6 months - 1 year 1
1 - 2 years 1
Adherence
Adherence Evaluations
Always 12
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 2
Not at all hard to take 10
Cost per month
Cost per month Evaluations
$200+ 2
$100-199 0
$50-99 0
$25-49 1
< $25 6
Not specified 3

What people switch to and from

Patients started taking Afatinib after stopping:

Treatment Patients
Chemotherapy 4
Erlotinib (Tarceva) 2
Gefitinib (Iressa) 1

Patients stopped taking Afatinib and switched to:

Treatment Patients
Osimertinib (Tagrisso) 2
Last updated:
There are no evaluations for Afatinib.